PUBLISHER: The Business Research Company | PRODUCT CODE: 1945346
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945346
An implantable biomaterial is a natural or synthetic material used in medical procedures to support, repair, or replace damaged tissues or biological structures.
The key material categories in implantable biomaterials include metallic, ceramic, polymeric, and natural materials. Metallic implants are commonly selected for orthopedic prostheses over polymeric and traditional ceramic materials due to their suitability for enhancing biological activity. The applications include dental, cardiovascular, ophthalmic, orthopedic, and others, and these materials are used in hospitals, ambulatory surgical centers, and specialty clinics.
Tariffs are impacting the implantable biomaterials market by increasing costs of imported raw materials such as titanium alloys, advanced polymers, and bio-ceramics. High-impact segments include metallic and ceramic biomaterials, with regions like Asia-Pacific and Europe experiencing supply chain and pricing pressures. These tariffs have raised manufacturing costs and slowed cross-border sourcing. However, they have also encouraged local material production, alternative sourcing strategies, and increased investment in domestic biomaterials innovation and manufacturing capabilities.
The implantable biomaterials market research report is one of a series of new reports from The Business Research Company that provides implantable biomaterials market statistics, including implantable biomaterials industry global market size, regional shares, competitors with a implantable biomaterials market share, detailed implantable biomaterials market segments, market trends and opportunities, and any further data you may need to thrive in the implantable biomaterials industry. This implantable biomaterials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The implantable biomaterials market size has grown strongly in recent years. It will grow from $165.43 billion in 2025 to $180.87 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to early adoption of metallic implants, growing prevalence of orthopedic disorders, increasing dental implant procedures, limited availability of bioresorbable materials, reliance on traditional surgical techniques.
The implantable biomaterials market size is expected to see strong growth in the next few years. It will grow to $264.59 billion in 2030 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to advancements in polymer and ceramic biomaterials, rising aging population, increasing cardiovascular and ophthalmic procedures, growth in regenerative medicine research, expansion of specialty clinics and surgical centers. Major trends in the forecast period include rising demand for biocompatible and bioactive materials, increasing use of implantable biomaterials in orthopedic and dental applications, growth in minimally invasive surgical procedures, advancements in long-term implant durability and performance, expanding adoption of natural and bio-resorbable biomaterials.
The rise in cardiovascular disease cases is increasingly supporting the expansion of the implantable biomaterial market. Cardiovascular diseases include a range of conditions that affect the heart and blood vessels. The growing number of cardiovascular disease cases has led to higher demand for implantable biomaterials used in medical devices and procedures to repair or replace damaged cardiovascular tissues. These biomaterials play a crucial role in improving treatment effectiveness, enhancing implant performance, and supporting better patient outcomes and quality of life. For example, in October 2025, according to the Australian Institute of Health and Welfare, an Australia-based government agency, an estimated 57,100 adults aged 25 years and older experienced acute coronary events in 2023, averaging around 156 cases per day. As a result, the increasing incidence of cardiovascular diseases is strengthening growth prospects for the implantable biomaterial market.
Leading companies operating in the implantable biomaterials market are focusing on developing innovative solutions, such as the TrabeculeX Continuum, to improve surgical precision, accelerate recovery, enhance patient outcomes, and integrate digital health monitoring with next-generation biomaterials. TrabeculeX Continuum is a technology platform that combines regenerative biomaterials with digital health tools to support continuous post-operative monitoring. For example, in January 2024, Xenco Medical LLC, a US-based medical technology company, launched TrabeculeX Continuum, enabling remote therapeutic monitoring, real-time provider communication, and advanced biomaterial architecture for improved bone healing.
In January 2023, Zimmer Biomet Holdings Inc., a US-based medical technology company, acquired Embody Inc. for $155 million. With this acquisition, Zimmer Biomet aimed to strengthen its sports medicine business by integrating Embody's advanced biointegrative soft tissue healing technologies into its existing product portfolio. Embody Inc. is a US-based medical device company specializing in collagen-based, biofabricated regenerative solutions, including implants such as TAPESTRY for tendon healing and rotator cuff repair.
Major companies operating in the implantable biomaterials market are BASF SE, 3M Company, Medtronic plc, Evonik Industries AG, Stryker Corporation, DuPont de Nemours Inc., Celanese Corporation, Zimmer Biomet Holdings Inc., Koninklijke DSM NV, Arthrex Inc., DePuy Synthes Companies, Carpenter Technology Corporation, Corbion NV, GELITA AG, CoorsTek Inc., CeramTec GmbH, Orthofix Holdings Inc., Invibio Biomaterial Solutions plc, Keystone Dental Inc., KLS Martin SE & Co., Collagen Matrix Inc., Cam Bioceramics BV, Aap Implantate AG, Berkeley Advanced Biomaterials Inc., AdvanSource Biomaterials Corporation, Collagen Solutions plc, Surgival SL, SBM France SAS.
North America was the largest region in the implantable biomaterials market in 2025. Western Europe was the second largest region in the global implantable biomaterials market report. The regions covered in the implantable biomaterials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the implantable biomaterials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The implantable biomaterial market consists of sales of glass-ceramic and bioactive glasses and calcium phosphate cements. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Implantable Biomaterials Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses implantable biomaterials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for implantable biomaterials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The implantable biomaterials market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.